The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mcelhaugh Michael J. since 2020.
This trader's CIK number is 1635326.
At the time of last reporting, Mcelhaugh Michael J. was the Interim President & CEO of Arbutus Biopharma Corp. (stock ticker symbol ABUS).
Also see all insider trading activities at Arbutus Biopharma Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ABUS | 0 | $0 | 23,790 | $78,102 | 0 | $0 |
| 2024 | ABUS | 0 | $0 | 10,164 | $23,509 | 0 | $0 |
| 2021 | ABUS | 0 | $0 | 20,000 | $100,000 | 0 | $0 |
| 2020 | ABUS | 0 | $0 | 60,000 | $300,280 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-04 | ABUS | Sale | 23,790 | 3.28 | 78,102 |
| 2024-02-02 | ABUS | Sale | 10,164 | 2.31 | 23,509 |
| 2021-02-09 | ABUS | Sale | 20,000 | 5.00 | 100,000 |
| 2020-12-14 | ABUS | Sale | 40,000 | 5.00 | 200,080 |
| 2020-07-23 | ABUS | Sale | 20,000 | 5.01 | 100,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcelhaugh Michael J. (Interim President & CEO of Arbutus Biopharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.